Fibromyalgia in Patient With Impaired Fasting Glucose

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03871946

Enrollment

146

Registered

2019-03-12

Start date

2015-08-15

Completion date

2016-12-31

Last updated

2019-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Brief summary

To assess the frequency of fibromyalgia among women with impaired fasting glucose.

Detailed description

Objective: To assess the frequency of fibromyalgia among women with impaired fasting glucose. Materials and Methods: The sample was selected from the patients who applied to the Internal Medicine clinic and whose fasting blood glucose level were ≥100 and \<126 mg/dL in their routine examination \[Group1 \] and patients whose fasting blood glucose were less than 100 constituted the control group \[Group2 \]. Oral glucose tolerance test \[OGTT \] has been applied to patients with impaired fasting glucose and whose 2nd hour OGTT levels were under 140 has been included. Patients were evaluated in terms of fibromyalgia according to modified 2010 ACR Fibromiyalgia Criteria. Functional status was assessed by using the Fibromyalgia Impact Questionnaire \[FIQ \].

Interventions

DIAGNOSTIC_TESToral glucose tolerance test (OGTT)

Implementation of OGTT: The patient was seated in a quiet room after 10-12 h of overnight fasting, and blood samples were drawn. Thereafter, 75 g glucose solution dissolved in 300 mL of water was administeredwithin 5 min. Two hours after this,another blood sample was drawn. During the test, the patient wasn't allowed to rest and eat, but not smoke.

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* the study group subjects: fasting blood glucose level was between 100 and 126 mg/dL; * the control group subjects: fasting blood glucose level was \< 100 mg/dL.

Exclusion criteria

* Patients with a severe systemic disease (chronic kidney disease, liver disease etc. ), * psychiatric disease, * hypothyroidism or hyperthyroidism, * any connective tissue disease * patients who used medications that influenced the fibromyalgia symptoms, such as analgesics, antidepressants, and anticonvulsive medications

Design outcomes

Primary

Measure	Time frame	Description
the frequency of fibromyalgia among women with impaired fasting glucose.	16 month	Moreover, a significantly higher proportion of Group 1 patients (26%, n = 19) than Group 2 patients (11%, n = 8) were diagnosed with FM

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026